54 /100
HIGH RISK
Score updated May 30, 2026

IPWR — Ideal Power Inc. Dilution Risk Tracker

Track IPWR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IPWR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
57
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
49%
📜 Warrant Exercise 60%
• Massive warrant overhang: 37% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 40%
• Score rose 30 points recently (worsening)
💰 Capital Raise 38%
• Active shelf registration ($12M, 10% of market cap)
• Active ATM program with $50M remaining capacity
🔔 Track IPWR — Get forecast alerts →

💹 Market Data

Market Cap$119.10M
Shares Outstanding16.01M
Float8.12M
Cash$16.41M
Debt$381.1K
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 4.07M shares
#1 AWM Investment Company, Inc. 1.20M shares
#2 AIGH Capital Management LLC 1.18M shares
#3 Alyeska Investment Group, L.p. 385.6K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest199.5K
Days to Cover1.0
% of Float2.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2017
EFFECT EFFECT Apr 03, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track IPWR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IPWR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for IPWR
📊 IPWR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IPWR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.